Rather than defend high list prices, Lilly and Novo are using scale itself as the new moatturning volume into their competitive weapon
10.1053/j.gastro.2015.05.008 200
As GLP-1R agonist therapies continue to expand in clinical use, further investigation is warranted to determine the oncogenic implications of this overexpression for thyroid cancer
Cadden IS, Partovi N, Yoshida EM (2007)
Indeed, an easy access to diagnosis and treatment is still missing to drug users, people in difficult socio-economic situations, migrants, prisoners, because of themselves or health policy
2mg of tesamorelin for 26 weeks has been shown to decrease 15% of the visceral adipose tissue which is equivalent to a 50mg reduction in triglyceride levels [5, 6]